Literature DB >> 15777183

Screening for protease substrate by polyvalent phage display.

Radislav Sedlacek1, Emily Chen.   

Abstract

Proteases are key regulators of many physiological and pathological processes [1,2], and are recognized as important and tractable drug candidates. Consequently, knowledge of protease substrate recognition and specificity promotes identification of biologically relevant substrates, helps elucidating a protease's biological function, and the design of specific inhibitors. Traditional methods for establishing substrate recognition profiles involve the identification of the scissile bond within a given protein substrate by proteomic methods such as Edman degradation. Then, synthetic peptide variants of this sequence can be screened in an iterative fashion to arrive at more optimized substrates. Even though it can be fruitful, this iterative strategy is biased toward the original substrate sequence and it is also tremendously cumbersome. Furthermore, it is not amenable to high throughput analysis. In 1993, Matthew & Wells presented a method for the use of monovalent "substrate phage" libraries for discovering peptide substrates for proteases, in which more than 10(7) potential substrates can be tested concurrently [3]. A library of fusion proteins was constructed containing randomized substrate sequences placed between a binding domain and the gene III coat protein of the filamentous phage, M13, which displays the fusion protein and packages the gene coding for it inside. Each fusion protein was displayed as a single copy on filamentous phagemid particles (substrate phage). This method allows one to rapidly survey the substrate recognition and specificity of individual or closely related members of proteases. Over the past decade, substrate phage screening has shown terrific utility in rapidly determining protease specificity and characterization of substrate recognition profile of proteases. In some cases, the structural insights of the catalytic domain were obtained from comparison of substrate specificity among closely related family of proteases [4-6]. The number of proteases (from various classes) characterized by this approach testifies to its power. Since the initial development of substrate phage library, different versions of the substrate phage cloning vectors have been constructed to further improve the utility of substrate phage display. This review will provide an overview of the construction of substrate phage display libraries, screening of substrate phage libraries, examples of application, summary and future directions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777183     DOI: 10.2174/1386207053258541

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  5 in total

1.  Substrate specificity of human kallikreins 1 and 6 determined by phage display.

Authors:  Hai-Xin Li; Bum-Yeol Hwang; Gurunathan Laxmikanthan; Sachiko I Blaber; Michael Blaber; Pavel A Golubkov; Pengyu Ren; Brent L Iverson; George Georgiou
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

2.  Substrate specificity of the anthrax lethal factor.

Authors:  M Yu Zakharova; S A Dubiley; D M Chudakov; A G Gabibov; I G Shemyakin; A V Kolesnikov
Journal:  Dokl Biochem Biophys       Date:  2008 Jan-Feb       Impact factor: 0.788

Review 3.  Progress in phage display: evolution of the technique and its application.

Authors:  Tomaz Bratkovic
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

4.  Substrate specificity of the Escherichia coli outer membrane protease OmpP.

Authors:  Bum-Yeol Hwang; Navin Varadarajan; Haixin Li; Sarah Rodriguez; Brent L Iverson; George Georgiou
Journal:  J Bacteriol       Date:  2006-11-03       Impact factor: 3.490

Review 5.  Peptide phage display as a tool for drug discovery: targeting membrane receptors.

Authors:  Peter Molek; Borut Strukelj; Tomaz Bratkovic
Journal:  Molecules       Date:  2011-01-21       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.